We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$63.3B
AUM Growth
+$192M
Cap. Flow
+$1.33B
Cap. Flow %
2.1%
Top 10 Hldgs %
14.31%
Holding
4,981
New
573
Increased
1,406
Reduced
1,427
Closed
1,256

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$561M
2
ACN icon
Accenture
ACN
+$435M
3
MRK icon
Merck
MRK
+$378M
4
NOC icon
Northrop Grumman
NOC
+$339M
5
V icon
Visa
V
+$308M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$439M
2
ZTS icon
Zoetis
ZTS
+$345M
3
MCD icon
McDonald's
MCD
+$343M
4
UNH icon
UnitedHealth
UNH
+$334M
5
SPGI icon
S&P Global
SPGI
+$279M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Industrials 11.25%
3 Healthcare 10.23%
4 Financials 10.22%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDV icon
3801
Avantis International Small Cap Value ETF
AVDV
$18.9B
-448
Closed -$29.5K
AVNT icon
3802
Avient
AVNT
$3.34B
-26,941
Closed -$1.17M
AVT icon
3803
Avnet
AVT
$7.25B
-1,851
Closed -$91.8K
AVUV icon
3804
Avantis US Small Cap Value ETF
AVUV
$30.3B
-711
Closed -$66.6K
AXGN icon
3805
Axogen
AXGN
$2.19B
-12,500
Closed -$101K
AXS icon
3806
AXIS Capital
AXS
$8.63B
-124,799
Closed -$8.11M
AXTA icon
3807
CALL
Axalta
AXTA
$7.22B
-13,400
Closed -$461K
AXSM icon
3808
Axsome Therapeutics
AXSM
$12.3B
-1,696
Closed -$135K
AZUL
3809
DELISTED
Azul
AZUL
-172
Closed -$1.34K
BAER icon
3810
Bridger Aerospace
BAER
$108M
-8,143
Closed -$40.9K
BAX icon
3811
Baxter International
BAX
$12.1B
-1,038
Closed -$44.4K
BBAG icon
3812
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$1.02B
-4,844
Closed -$222K
BBCA icon
3813
JPMorgan BetaBuilders Canada ETF
BBCA
$10.9B
-6,535
Closed -$437K
BBEU icon
3814
JPMorgan BetaBuilders Europe ETF
BBEU
$9.17B
-7,142
Closed -$424K
BBIO icon
3815
BridgeBio Pharma
BBIO
$16.5B
-2,432
Closed -$75.2K
BCAL icon
3816
Southern California Bancorp
BCAL
$681M
-34,549
Closed -$515K
BCAT icon
3817
BlackRock Capital Allocation Term Trust
BCAT
$1.61B
-84,178
Closed -$1.4M
BCE icon
3818
BCE
BCE
$19.8B
-432,911
Closed -$14.7M
BCI icon
3819
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$2.94B
-4,449
Closed -$88K
BCRX icon
3820
BioCryst Pharmaceuticals
BCRX
$2.43B
-667,394
Closed -$3.39M
BDC icon
3821
Belden
BDC
$4.12B
-3,008
Closed -$279K
BDX icon
3822
CALL
Becton Dickinson
BDX
$43.8B
-2,400
Closed -$594K
BDX icon
3823
PUT
Becton Dickinson
BDX
$43.8B
-2,000
Closed -$495K
BEEM icon
3824
Beam Global
BEEM
$23.3M
-536
Closed -$3.65K
BEEP icon
3825
Mobile Infrastructure Corp
BEEP
$72.5M
-301
Closed -$1.1K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2024 Portfolio in Review

As of Q2 2024, Qube Research & Technologies (QRT) held 4,981 positions worth $63.3B, up 0.3% from $63.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Qube Research & Technologies (QRT)'s Q2 2024 filing shows 573 new, 1,406 increased, 1,427 reduced and 1,256 closed positions. Its largest new stake was Coinbase: 273,144 shares worth $60.7M. The largest sale was NVIDIA, an estimated $439M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Qube Research & Technologies (QRT)'s largest Q2 2024 buy was Coinbase: 273,144 shares worth $60.7M.
  • Qube Research & Technologies (QRT) added most to Broadcom in Q2 2024, an estimated $561M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2024 reduction was NVIDIA, cutting an estimated $439M.
  • Qube Research & Technologies (QRT) fully exited Palantir in Q2 2024, selling an estimated $161M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 14% of its $63.3B portfolio in Q2 2024.
  • Qube Research & Technologies (QRT) opened 573 new positions and closed 1,256 in Q2 2024.
  • Qube Research & Technologies (QRT)'s portfolio value rose 0.3% quarter-over-quarter to $63.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.